487 related articles for article (PubMed ID: 24294355)
1. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
[TBL] [Abstract][Full Text] [Related]
2. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
3. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
4. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
Saleh DO; Ahmed RF; Amin MM
Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.
Clarke JD; Sharapova T; Lake AD; Blomme E; Maher J; Cherrington NJ
J Appl Toxicol; 2014 Jun; 34(6):726-32. PubMed ID: 24217942
[TBL] [Abstract][Full Text] [Related]
6.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
8. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
Zhang S; Wang J; Liu Q; Harnish DC
J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
[TBL] [Abstract][Full Text] [Related]
10. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
[TBL] [Abstract][Full Text] [Related]
11. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model.
Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
J Gastroenterol Hepatol; 2021 Sep; 36(9):2592-2600. PubMed ID: 33600604
[TBL] [Abstract][Full Text] [Related]
12. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.
Wang RQ; Nan YM; Wu WJ; Kong LB; Han F; Zhao SX; Kong L; Yu J
Lipids Health Dis; 2011 Feb; 10():31. PubMed ID: 21314960
[TBL] [Abstract][Full Text] [Related]
13. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Koca SS; Bahcecioglu IH; Poyrazoglu OK; Ozercan IH; Sahin K; Ustundag B
Inflammation; 2008 Apr; 31(2):91-8. PubMed ID: 18066656
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
15. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
[TBL] [Abstract][Full Text] [Related]
17. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice.
Zang S; Wang L; Ma X; Zhu G; Zhuang Z; Xun Y; Zhao F; Yang W; Liu J; Luo Y; Liu Y; Ye D; Shi J
Cell Biochem Biophys; 2015 Nov; 73(2):479-487. PubMed ID: 27352342
[TBL] [Abstract][Full Text] [Related]
19. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
20. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T
Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
